The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
P/E ratio
24.68 53.31 39.93 37.19

+8 more quarters

P/S ratio
3.29 2.90 3.80 3.40
P/FCF ratio
20.59 21.54 32.15 32.09
P/Operating CF
40.85 67.10 60.53 56.15
P/B ratio
1.68 1.49 1.89 1.69
EV/Sales
3.86 3.45 4.38 3.99
EV/EBITDA
17.61 16.53 16.58 15.39
EV/FCF
24.11 25.61 36.98 37.62
Current Ratio
1.22 1.27 1.34 1.89
Net Debt/EBITDA
7.55 36.05 7.70 10.03
Debt/Equity
0.31 0.30 0.30 0.30
Earnings Yield
4.05% 1.88% 2.50% 2.69%
Free Cash Flow Yield
4.86% 4.64% 3.11% 3.12%
Free Cash Flow per Share
1.41 0.49 0.81 0.75
Book value per Share
43.15 42.25 42.72 41.38
Free Cash Flow
273.00 96.40 158.70 149.90
EV/EBIT
30.04 29.30 25.45 23.89
Other line items

Show all line items

Columns are period end dates